Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $15,957 - $20,871
-183 Reduced 0.21%
86,938 $9.33 Million
Q1 2022

May 13, 2022

SELL
$94.19 - $124.49 $382,317 - $505,304
-4,059 Reduced 4.45%
87,121 $9.66 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $477,562 - $555,445
3,994 Added 4.58%
91,180 $11.7 Million
Q3 2021

Nov 09, 2021

BUY
$109.17 - $142.35 $2.99 Million - $3.89 Million
27,353 Added 45.72%
87,186 $11.6 Million
Q2 2021

Aug 11, 2021

BUY
$100.34 - $115.69 $6 Million - $6.92 Million
59,833 New
59,833 $6.47 Million
Q4 2020

Feb 09, 2021

SELL
$85.88 - $105.36 $8.3 Million - $10.2 Million
-96,663 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $1.25 Million - $1.59 Million
17,148 Added 21.57%
96,663 $8.28 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $3.82 Million - $6.28 Million
79,515 New
79,515 $5.83 Million
Q1 2019

May 15, 2019

SELL
$29.84 - $43.92 $393,828 - $579,656
-13,198 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $47.6 Million - $73.7 Million
-1,589,750 Reduced 99.18%
13,198 $412,000
Q3 2018

Nov 14, 2018

BUY
$40.12 - $45.55 $23.9 Million - $27.1 Million
594,489 Added 58.95%
1,602,948 $73 Million
Q2 2018

Aug 14, 2018

BUY
$38.72 - $42.52 $39 Million - $42.9 Million
1,008,459 New
1,008,459 $42.2 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.